Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ophir Vermesh, M.D., Ph.D.

Concepts (115)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ophir Vermesh's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ophir Vermesh has written about over time.
Microfluidic Analytical Techniques, 3 publications between 2009 and 2011, average publication date July 2010. Blood Proteins, 4 publications between 2008 and 2017, average publication date September 2011. Nanospheres, 1 publications between 2015 and 2015, average publication date February 2015. Contrast Media, 3 publications between 2015 and 2018, average publication date May 2016. Lung Neoplasms, 2 publications between 2016 and 2018, average publication date July 2017. Ultracentrifugation, 1 publications between 2017 and 2017, average publication date November 2017. Neoplasms, Experimental, 2 publications between 2018 and 2020, average publication date May 2019. Copper Radioisotopes, 2 publications between 2018 and 2020, average publication date July 2019. Receptors, OX40, 2 publications between 2018 and 2020, average publication date July 2019. T-Lymphocytes, 4 publications between 2018 and 2020, average publication date January 2020. Interferon-beta, 1 publications between 2020 and 2020, average publication date May 2020. Molecular Imaging, 3 publications between 2018 and 2022, average publication date July 2020. Hodgkin Disease, 1 publications between 2022 and 2022, average publication date November 2022.

To see the data from this visualization as text, click here.
Vermesh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (115)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.